Oratox - Fucus Vesiculosus, Lymph Node, Medula Ossis Suis, Thymus, Thyroidinum, Calcarea Muriatica, Iodium
Navigation: NDC > Supplier starting with: D > DESERET BIOLOGICALS, INC.Field | Value |
---|---|
NDC Code: | 43742-0170 |
Proprietary Name: | Oratox |
Suffix: | |
Non-Proprietary Name: | Fucus Vesiculosus, Lymph Node, Medula Ossis Suis, Thymus, Thyroidinum, Calcarea Muriatica, Iodium |
Dosage Form: | LIQUID |
Method: | ORAL |
Original Marketing Date: | 31-10-2012 |
Category Name: | UNAPPROVED HOMEOPATHIC |
Application Number: | |
Labeler: | DESERET BIOLOGICALS, INC. |
Substance Name: | CALCIUM CHLORIDE; COPPER; EUGENOL; FORMALDEHYDE; FUCUS VESICULOSUS; GOLD; IODINE; LIDOCAINE; MERCURIUS SOLUBILIS; MOLYBDENUM; NICKEL; PALLADIUM; SELENIUM; SILVER; SODIUM CHLORIDE; SODIUM FLUORIDE; SUS SCROFA BONE MARROW; SUS SCROFA LYMPH; SUS SCROFA THYMUS; SUS SCROFA THYROID; TIN; TITANIUM; VANADIUM; ZINC |
Active Numerator Strength: | 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 8; 8; 8; 8; 12; 12; 12; 12 |
Active Ingredient Unit: | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
Pharm Classes: | Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient] |
DEA Schedule: |